Search results
8 Ways to Cope With a Fear of Needles When You Have a Chronic Illness
Self via Yahoo News· 3 days agoPlacing a cold towel or an ice pack on the back of your neck could also help you feel better if you...
A bench and a grandmother's ear: Zimbabwe's novel mental health therapy spreads overseas
Medical Xpress· 6 days agoAfter her son, the family's shining light and only breadwinner, was arrested last year, Tambudzai...
From FLiRT to FLuQE: what to know about the latest COVID variants on the rise
Medical Xpress· 14 hours agoAlong with the usual viral suspects, such as influenza, RSV, and rhinoviruses (which cause the...
Quebec pharmacists have more powers: What are they?
CTV Montreal News· 5 days agoLast month, the Quebec government tabled Bill 67, saying it was going to give pharmacists more power to help people with certain health concerns. "I...
Life-Saving Eye Technologies; TechBullion Q&A Interview With Thomas Ruggia, President and CEO,...
TechBullion· 7 hours agoMy name is Thomas Ruggia, and I am the President and CEO of Samsara Vision since July 2020. Samsara...
Interactive Strength Inc. (Nasdaq:TRNR) Regains Compliance with Nasdaq Listing Rule about Minimum...
Digital Journal· 18 hours agoInteractive Strength Inc. is listed on ...ergonomic movement, CLMBR is safe for most ages and levels of ability and can be found at gyms and fitness studios, hotels, and physical therapy ...
Quebec pharmacists may soon have more powers: What are they?
CTV Montreal News· 5 days agoLast month, the Quebec government tabled Bill 67, saying it would again give pharmacists more power...
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To...
Digital Journal· 1 day agoAristotle®, as well as additional cancer diagnostics are processed at the Company's clinical laboratory, StageZero...Richmond, Virginia. StageZero Life Sciences trades on the Toronto Stock exchange ...
Poland's Celon Pharma sees schizophrenia drug as 'billion-dollar' product
Reuters via Yahoo Canada News· 13 hours agoLast Friday, the company said the drug achieved favourable results in the second phase of clinical studies, showing high efficacy and good tolerance among patients. The CEO said that with around ...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Finance Canada· 3 days agoAccording to Lilly, Kisunla is the only Aβ targeting therapy that can be discontinued when amyloid...